An ear infection occurs when certain pathogens such as bacteria and viruses cause pain and inflammation, and certain kind of fluids infect the ear. Most ear infections are acute and do not cause much harm. However, chronic infections may cause lethal damage to the middle and inner ear. The small tubes running from the ear to the back of the throat are known as the Eustachian tubes. Pain, swelling, or inflammation in the tubes cause fluid to build up, and this leads to infection. Factors that boosts the risk of developing an ear infection are weather changes, cough, cold, altitude changes, recent illness, exposure to cigarette smoke, and others. Pain and pus-like ear drainage are the common results of an ear infection. However, ear infections can also cause serious complications such as hearing loss, speech delay in children, infection of the mastoid bone in the skull, bacterial infection in the brain and spinal cord, ruptured eardrum and others symptoms.
Increase in the incidence of ear infection cases, rise in health care expenditure, and rise in the risk of infection are driving the global ear infection treatment market. Moreover, rise in demand for surgeries such as laparoscopy supported by government investments is anticipated to propel the global ear infection treatment market during the forecast period. Continuous innovation and rise in awareness about ear infections and their common causes are expected to augment the global ear infection treatment market from 2018 to 2026. Initiatives by government to focus on the development of the surgery segment and investment in health care are other factors likely to boost the growth of the global ear infection treatment market in the next few years. Moreover, prevalence of ear infections in children is high as compared to that in adults. This is expected to propel the market. However, patent loss of drugs is likely to restrain the growth of the global ear infection treatment market. Also, high cost of surgeries and complications related to them are expected to hamper the growth of the global ear infection market.
The global ear infection treatment market can be segmented based on type, pathogen, treatment, end-user, and region. In terms of type, the global ear infection treatment market can be classified into inner ear, middle ear, and outer ear. Middle ear infections are more common in children. Acute otitis media is the most common middle ear infection. Swelling, inflammation, and mucus in the Eustachian tubes, which run from the middle ear, result in middle ear infections. Based on pathogen, the global ear infection treatment market can be classified into bacteria, viruses, and others. Based on treatment, the global ear infection treatment market can be segmented into drugs, surgery, and others. Innovative surgical treatment such as minimally invasive laparoscopy is the future of ear infection treatment. However, surgeries are complicated and are only performed if drugs are not effective in curing ear infections. In terms of end-user, the global market can be divided into hospitals, clinics, and others.
In terms of region, the global ear infection treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increasing demand for surgeries to treat ear infections and rise in government expenditure are boosting the global market. North America dominated the global market in 2017, owing to the focus of major health care companies and medical device companies on investing in providing innovative offerings. Moreover, collaborations between medical device companies and insurance companies to offer insurance coverage for the treatment of ear infections in developed countries and rise in awareness about the causes of ear infection and its treatments are projected to boost the global market.
Europe is a prominent region of the market, owing to the availability of treatment methods for ear infections, high income of the population, and rise in demand for effective treatment. Major countries such as Germany and the U.K. have significant demand for the treatment of ear infections and are backed up by a strong medical device industry. Asia Pacific is a rapidly expanding region of the market. The ear infection treatment market in the region is anticipated to expand at a rapid pace during the forecast period. Rise in health care expenditure, rapidly expanding health care industry, and large unmet needs are expected to drive the market in Asia Pacific during the forecast period. Technological advancement in introducing minimally invasive surgeries and rise in disposal income are likely to boost market in Asia Pacific during the forecast period. Prevalence of ear infections and increase in ear surgeries are likely to propel the global market during the forecast period. The ear infection treatment market in Middle East & Africa is likely to expand at a moderate pace due to poor economic conditions and volatile political conditions in the region.
Major players operating in the global ear infection treatment market include American Diagnostic Corporation, Pfizer Inc., Heine USA Ltd., Torque Pharmaceuticals Pvt. Ltd., Medtronic, Intersect ENT, Inc., Olympus Corporation, and Grace Medical.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.